Cargando…

Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways

Prostate cancer is the most common illness affecting men worldwide. Although much progress has been made in the study of prostate cancer prevention and treatment, less attention has been paid to the molecular mechanism of the disease. The molecular arrangement by which atractylenolide II (ATR II) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Nasser, Moussa Ide, Adlat, Salah, Ming Jiang, Ming, Jiang, Nan, Gao, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320989/
https://www.ncbi.nlm.nih.gov/pubmed/30545141
http://dx.doi.org/10.3390/molecules23123298
_version_ 1783385335403642880
author Wang, Jing
Nasser, Moussa Ide
Adlat, Salah
Ming Jiang, Ming
Jiang, Nan
Gao, Li
author_facet Wang, Jing
Nasser, Moussa Ide
Adlat, Salah
Ming Jiang, Ming
Jiang, Nan
Gao, Li
author_sort Wang, Jing
collection PubMed
description Prostate cancer is the most common illness affecting men worldwide. Although much progress has been made in the study of prostate cancer prevention and treatment, less attention has been paid to the molecular mechanism of the disease. The molecular arrangement by which atractylenolide II (ATR II) induces human prostate cancer cytotoxicity was comprehensively examined in the present study. As indicated by the results, ATR II could inhibit prostate cancer cell proliferation and promote DU145 and LNCaP cell apoptosis through induced G2/M cell cycle arrest. The cell apoptosis process induced by ATR II in both DU145 and LNCaP cells was associated with its ability to inhibit androgen receptor (AR) with overexpression of protein inhibitor of activated STAT-1 (PIAS1) and the repression of Janus kinase (Jak2) signaling pathways. The data from the present study demonstrated the antitumor effects and the potential pharmacological application of ATR II as an efficient drug for prostate cancer treatment.
format Online
Article
Text
id pubmed-6320989
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63209892019-01-14 Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways Wang, Jing Nasser, Moussa Ide Adlat, Salah Ming Jiang, Ming Jiang, Nan Gao, Li Molecules Article Prostate cancer is the most common illness affecting men worldwide. Although much progress has been made in the study of prostate cancer prevention and treatment, less attention has been paid to the molecular mechanism of the disease. The molecular arrangement by which atractylenolide II (ATR II) induces human prostate cancer cytotoxicity was comprehensively examined in the present study. As indicated by the results, ATR II could inhibit prostate cancer cell proliferation and promote DU145 and LNCaP cell apoptosis through induced G2/M cell cycle arrest. The cell apoptosis process induced by ATR II in both DU145 and LNCaP cells was associated with its ability to inhibit androgen receptor (AR) with overexpression of protein inhibitor of activated STAT-1 (PIAS1) and the repression of Janus kinase (Jak2) signaling pathways. The data from the present study demonstrated the antitumor effects and the potential pharmacological application of ATR II as an efficient drug for prostate cancer treatment. MDPI 2018-12-12 /pmc/articles/PMC6320989/ /pubmed/30545141 http://dx.doi.org/10.3390/molecules23123298 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Jing
Nasser, Moussa Ide
Adlat, Salah
Ming Jiang, Ming
Jiang, Nan
Gao, Li
Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways
title Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways
title_full Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways
title_fullStr Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways
title_full_unstemmed Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways
title_short Atractylenolide II Induces Apoptosis of Prostate Cancer Cells through Regulation of AR and JAK2/STAT3 Signaling Pathways
title_sort atractylenolide ii induces apoptosis of prostate cancer cells through regulation of ar and jak2/stat3 signaling pathways
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320989/
https://www.ncbi.nlm.nih.gov/pubmed/30545141
http://dx.doi.org/10.3390/molecules23123298
work_keys_str_mv AT wangjing atractylenolideiiinducesapoptosisofprostatecancercellsthroughregulationofarandjak2stat3signalingpathways
AT nassermoussaide atractylenolideiiinducesapoptosisofprostatecancercellsthroughregulationofarandjak2stat3signalingpathways
AT adlatsalah atractylenolideiiinducesapoptosisofprostatecancercellsthroughregulationofarandjak2stat3signalingpathways
AT mingjiangming atractylenolideiiinducesapoptosisofprostatecancercellsthroughregulationofarandjak2stat3signalingpathways
AT jiangnan atractylenolideiiinducesapoptosisofprostatecancercellsthroughregulationofarandjak2stat3signalingpathways
AT gaoli atractylenolideiiinducesapoptosisofprostatecancercellsthroughregulationofarandjak2stat3signalingpathways